Institute for Health Care Delivery Science

TCI Biostatistics Shared Resource Facility

Our biostatisticians play a key role in multidisciplinary cancer research in a variety of ways, including designing studies to address pertinent hypotheses; guiding the creation of appropriate databases; ensuring the feasibility of the planned analyses; analyzing study data; providing proper interpretation of results; and developing novel design and analytic methods.

Given the diversity of scientific expertise and research within the Tisch Cancer Institute (TCI), the Biostatistics Shared Resource Facility (BSRF) provides support to a substantial number of projects, encompassing a broad research spectrum. With this in mind, our principal objective at BSRF is to provide biostatisticians with expertise in diverse types of cancer as well as a comprehensive coverage of statistical methodologies. Specifically, the four aims of BSRF are to:

  • Establish a scientific and administrative structure that supports investigators from a broad background and creates a collegial environment
  • Provide high-quality consultation in research design and biostatistical analysis
  • Train laboratory and clinical investigators in the quantitative aspects of research
  • Support methodological research for development of innovative research design and implementation of newly published analytic methods

The BSRF is available to any cancer investigator in the Icahn School of Medicine at Mount Sinai, whether you are a basic scientist, clinician, epidemiologist, psychologist, behavioral scientist, or other type of researcher. As an investigator you are able to access the facility via online requests for new projects through the facility website or by contacting the members directly for work on ongoing investigations.

The shared resource director will respond to online requests for statistical supports using the priority formulation of:

  • P1A. Planning of Investigator-Initiated clinical studies
  • P1B. Preparation of NCI/NIH grant submission
  • P1C. Analysis of NCI/NIH funded projects (presentation to scientific meetings and manuscript submission are given higher prioritization)
  • P2A. Preparation of grant submission to non-NIH agencies
  • P2B. Analysis for projects funded by non-NIH agencies (presentation to scientific meetings and manuscript submission are given higher prioritization
  • P3. All others (unfunded exploratory or training related work)

To request services please fill out a request form

How long does it take for statistical service timelines?

All Your requests received through eRAP will be assigned to a TCI-BSRF statistician within two business days. Once assigned, a statistician will respond to your inquiry within three business days to arrange for the first meeting. Timeline for the work to be done will be discussed in this meeting. The time that it takes a protocol, once submitted to a Disease-focus group (DFG), where the statistician generally gets the first draft of the study, to reach its submission to Protocol Review Monitoring Committee (PRMC) varies from 2-4 weeks. For protocols, mMovement to PRMC requires approval from the ‘Biostatistics Design Workshop’, a committee of all statisticians in the TCI-BSRF that meets weekly on Thursdays from 2-3 pm. For grant applications, time for development of the statistical sections for a grant also ranges between 2-4 weeks depending on the readiness of the proposal in terms of having all information needed for writing the statistical sections.

Members of the TCI Biostatistics Shared Resource Facility include:

Meng Ru, MS: As a Biostatistician joining Mount Sinai in June 2016, Meng's roles at The Tisch Cancer Institute Biostatistics Core and I-HDS include developing and reviewing clinical protocols presented in Biostatistics Design Workshop and providing statistical consultation for clinical research. She is experienced with multiple imputation, generalized mixed models and survival analysis. Her work with collaborators in the field of radiation oncology, head and neck, multiple myeloma and breast cancer has led to several peer-reviewed publications.

Jung-Yi (Joyce) Lin, MS: Joyce joined Mount Sinai in June 2017 after she earning her MS degree from the department of biostatistics at the University of Pittsburgh in April 2017. After joining Mount Sinai as a biostatistician, she finished several cancer-related research efforts including lab experiments, studies related to NCDB, and oncology healthcare research.

Hsin-Hui (Vivien) Huang, MD, PhD, MS, MPH: Dr. Huang worked as a medical oncologist before pursuing her PhD of Epidemiology at the University of Pittsburgh where she was a biostatistician in flu vaccine projects and for the Study of Women's Health Across the Nation (SWAN). Her PhD dissertation focused on methods of network meta-analyses, adverse effects of breast cancer hormone treatment on cardiovascular disease risk, and cohort studies using electronic medical records.